PIEZO1 and Alzheimer disease: We are the first group to focus specifically on the effect of TMAS on microglial Piezo1 in AD, and we cannot exclude the possibility that TMAS may also exert its beneficial effects on AD through Piezo1 expressed on other types of brain cells (e.g., astrocytes, neurons, and oligodendrocytes).